2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Relapsed Peripheral T-Cell Lymphoma: new trials by email Literature Review of Relapsed Peripheral T-Cell Lymphoma trials Research Report on Relapsed Peripheral T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine Brentuximab Vedotin - induction, Gemcitabine, Brentuximab Vedotin - maintenance - Refractory Peripheral T-Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma | Phase 2 | Completed | The Lymphoma Academic Research Organisation | 71 | 2018-04-10 | 2025-07-30 |
| Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies Folotyn and Leucovorin, Folic Acid, Vitamin B12 - Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma | Phase 2 | Completed | Acrotech Biopharma Inc. | 36 | 2014-07-01 | 2019-11-20 |
Lymphoma, T-Cell, Peripheral (2) · Lymphoma, T-Cell (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma, T-Cell (1)
10-propargyl-10-deazaaminopterin (1) · Brentuximab Vedotin (1) · Folic Acid (1) · Gemcitabine (1) · Leucovorin (1) · Vitamin B 12 (1)
Acrotech Biopharma Inc. (1) · The Lymphoma Academic Research Organisation (1)
Belgium (1) · France (1) · United States (1)
Wasim Khan, MD (1)